Literature DB >> 11912467

Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998.

Shunzhang Ye1, Xiaohong Su, Qianqiu Wang, Yueping Yin, Xiuqin Dai, Houhua Sun.   

Abstract

BACKGROUND: The prevalence of sexually transmitted diseases (STDs) has been increasing in China since the 1980s. Because gonorrhea is the most frequently reported STD there, information on the antimicrobial susceptibility of Neisseria gonorrhoeae will aid in its control. GOAL: To investigate the antimicrobial susceptibility of N gonorrhoeae isolates in China and to provide data for formulation of treatment guidelines and control policies.
METHODS: The agar dilution technique was used to determine antimicrobial susceptibility, and acidimetric method was used to test for penicillinase-producing N gonorrhoeae.
RESULTS: A total of 3186 gonococcal isolates were tested during the 6-year study period. The rate of resistance to penicillin was 66.70%; 8.14% of isolates were penicillinase-producing N gonorrhoeae. The percentage of tetracycline-resistant isolates was 92.03%, and that of highly tetracycline-resistant isolates was 4.65%. The rate of resistance to ciprofloxacin was also relatively high (34.25%). The rates of resistance to spectinomycin and ceftriaxone were 0.44% and 0.57%.
CONCLUSIONS: The gonococcal isolates in China are relatively highly resistant to penicillin, tetracycline, and ciprofloxacin, but most of them are still susceptible to spectinomycin and ceftriaxone. Standardized treatment of gonorrhea is needed to prevent further spread of resistant gonococcal strains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912467     DOI: 10.1097/00007435-200204000-00010

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  14 in total

1.  Perianal abscess due to Neisseria gonorrhoeae: an unusual case in the post-antibiotic era.

Authors:  Y El-Dhuwaib; B J Ammori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

2.  Novel Genes Related to Ceftriaxone Resistance Found among Ceftriaxone-Resistant Neisseria gonorrhoeae Strains Selected In Vitro.

Authors:  Zijian Gong; Wei Lai; Min Liu; Zhengshuang Hua; Yayin Sun; Qingfang Xu; Yue Xia; Yue Zhao; Xiaoyuan Xie
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 3.  Gonorrhoea.

Authors:  Sarah Creighton
Journal:  BMJ Clin Evid       Date:  2011-03-14

Review 4.  Gonorrhoea.

Authors:  Sarah Creighton
Journal:  BMJ Clin Evid       Date:  2014-02-21

5.  Socioeconomic disparity in healthcare-seeking behavior among Chinese Women with genitourinary symptoms.

Authors:  Qi Zhang; Diane Lauderdale; Shanshan Mou; William I Parish; Edward O Laumann; John Schneider
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

6.  Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario.

Authors:  Kaede V Ota; Frances Jamieson; David N Fisman; Karen E Jones; Itamar E Tamari; Lai-King Ng; Lynn Towns; Prasad Rawte; Alessandro Di Prima; Tom Wong; Susan E Richardson
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

Review 7.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

Review 8.  Gonorrhoea.

Authors:  John S Moran
Journal:  BMJ Clin Evid       Date:  2007-03-01

9.  Developing a system to predict laboratory-confirmed chlamydial and/or gonococcal urethritis in adult male emergency department patients.

Authors:  Roland C Merchant; Dina M DePalo; Tao Liu; Josiah D Rich; Michael D Stein
Journal:  Postgrad Med       Date:  2010-01       Impact factor: 3.840

Review 10.  An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Authors:  Achchhe Lal Patel; Uma Chaudhry; Divya Sachdev; Poonam Nagpal Sachdeva; Manju Bala; Daman Saluja
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.